Wiseguyreports.Com Adds “Virus Filtration -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database
Virus Filtration Market is accounted for $2.22 billion in 2016 and expected to grow at a CAGR of 13.7% to reach $5.46 billion by 2023. Factors like stipulation for biological products, increasing investment in R&D, prevalence of chronic diseases, presence of a large genome pool are boosting the market growth. However, intense competition among vendors and stringent regulations for validation of filtration products are restraining the market growth. Increasing pharmaceutical outsourcing and adoption of single-use technologies will provide ample growth opportunity.
Based on technology, advances in filtration technology are having the biggest impact on viral clearance. The newer generation virus filters have higher fluxes, larger product capacities, and increased virus removal capabilities, with some also offering steam-in-place (SIP) capabilities, which enable their use in closed processes. Filter sterilization of production media using nanofilters is one possible measure taken by companies. FDA and the European Medicines Agency have adopted guidelines for viral safety in relation to biologics.
Based on Application, Biologic products are at risk from chemical impurities, bacteria and fungi, and from viruses. Biopharmaceuticals manufacturers are required to create products that are safe for use in humans. This approach is required for therapies, such as monoclonal antibodies, blood products, recombinant products, tissue-derived materials and some medical devices, where risk assessments identify a gap in the viral safety. The prevalence of diabetes and new cancer cases leads to development of therapeutics, thus introducing new viral clearance products.
North America dominated the market during the forecast period. As many established biotechnology and biopharmaceutical industry has spiked the demand for viral filtration products in this region. However, Asia Pacific is projected to grow at highest CAGR during the forecast period due to presence of untapped growth opportunities in the China, India, and Indonesia.
Some of the key players in Global Virus Filtration market are
Charles River Laboratories International, Inc., Sigma-Aldrich Corporation, WuXiPharmaTech (Cayman) Inc., Sartorius AG, Pall Corporation, Lonza Group Ltd., Merck KGaA, Asahi Kasei Medical Co., Ltd., Danaher, GE Healthcare Life Sciences, Thermo Fisher Scientific Inc. and Pall Corporation.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/2769011-virus-filtration-global-market-outlook-2017-2023
End Users Covered:
• Academic Institutes & Research Laboratories
• Medical Devices Companies
• Biopharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Air Purification
• Water Purification
• Medical Devices
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
Table of Content
1 Executive Summary
3 Market Trend Analysis
10 Key Player Activities
11 Leading Companies
11.1 Charles River Laboratories International, Inc.
11.2 Sigma-Aldrich Corporation
11.3 WuXiPharmaTech (Cayman) Inc.
11.4 Sartorius AG, Pall Corporation
11.5 Lonza Group Ltd.
11.6 Merck KGaA
11.7 Asahi Kasei Medical Co., Ltd.
11.9 GE Healthcare Life Sciences
11.10 Thermo Fisher Scientific Inc.
11.11 Pall Corporation
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)